Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract (Q70229777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

N Kan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

K Ohgaki

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

T Inamoto

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

H Kodama

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 January 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

215-222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

Brief communication: In vivo protection against murine plasma cell tumor growth by in vitro activated syngeneic lymphocytes

9 October 2019

cites work

1 reference

12 December 2020

Biochemical relationship between murine immune interferon and a killer cell helper factor

1 reference

12 December 2020

Generation of cytotoxic lymphocytes to syngeneic tumors by using co-stimulator (Interleukin 2): in vivo activity

1 reference

12 December 2020

T cell growth factor: parameters of production and a quantitative microassay for activity

1 reference

12 December 2020

Immunotherapy of lethal metastases by lymphocytes sensitized against tumor cells in vitro

1 reference

12 December 2020

In vivo kinetics of murine lymphoid cells: in relation to local adoptive cancer immunotherapy

1 reference

12 December 2020

Different immunosuppression on specific anti-tumor and non-specific cellular immunity of tumor-bearing mice following tumor growth

1 reference

12 December 2020

Long term culture of tumour-specific cytotoxic T cells

1 reference

12 December 2020

Generation of cytotoxic T lymphocytes in vitro. II. Effect of repeated exposure to alloantigens on the cytotoxic activity of long-term mixed leukocyte cultures

1 reference

12 December 2020

Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts

1 reference

12 December 2020

Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF)

1 reference

12 December 2020

Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2

1 reference

12 December 2020

In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors

1 reference

12 December 2020

Intrapleural administration of OK432 in cancer patients: Activation of nk cells and reduction of suppressor cells

1 reference

12 December 2020

Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2

1 reference

12 December 2020

A simplified method for the production of murine T-cell growth factor free of lectin

1 reference

12 December 2020

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

1 reference

12 December 2020

New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival

1 reference

12 December 2020

In vitro induction of cell-mediated immunity to murine leukemia cells. I. Optimization of tissue culture conditions for the generation of cytotoxic lymphocytes

1 reference

12 December 2020

Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2

1 reference

12 December 2020

Studies on the Anticancer and Streptolysin S-Forming Abilities of Hemolytic Streptococci

1 reference

12 December 2020

In vitro generation of cytotoxicity against autologous human tumour biopsy cells

1 reference

12 December 2020

Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells

1 reference

12 December 2020

Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro

1 reference

12 December 2020

Specific adoptive immunotherapy by local transfer of cultured syngeneic spleen cells for mammary carcinoma in mice

1 reference

12 December 2020

In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes

1 reference

12 December 2020

Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression

1 reference

12 December 2020

Generation of cytotoxic T lymphocytes in vitro. V. Response of normal and immune spleen cells to subcellular alloantigens

1 reference

12 December 2020

Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor

1 reference

12 December 2020

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 reference

12 December 2020

Differential activation of cytotoxic and suppressor T cells against syngeneic tumors in the mouse

1 reference

12 December 2020

The fate of interleukin-2 after in vivo administration

1 reference

12 December 2020

The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors

1 reference

12 December 2020

Cancer immunotherapy by local transfer of autologous T lymphocytes cultured with T cell growth factor and autologous tumor extract: a clinical trial

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00205514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334553%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference